{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-003091","form_type":"8-K","ticker":"ENVB","cik":"0000890821","company_name":"Enveric Biosciences, Inc.","filed_at":"2025-01-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.705535+00:00","generated_at":"2026-05-27T22:49:12.081981+00:00","sec_items":["3.03","5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Enveric Biosciences announces 1-for-15 reverse stock split effective Jan 27, 2025","bullets":["Shareholders approved reverse split at a special meeting on Jan 17, 2025; ratio range 1:10 to 1:100.","Board set ratio at 1-for-15; outstanding shares to reduce from ~10.4M to ~692,580.","No fractional shares; rounding up to next whole number; authorized shares remain 100M.","Trading symbol ENVB unchanged; new CUSIP 29405E 406; adjusted trading begins Jan 27."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-003091","json":"https://secwatch.observer/filing/0001493152-25-003091.json","markdown":"https://secwatch.observer/filing/0001493152-25-003091.md","text":"https://secwatch.observer/filing/0001493152-25-003091.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000149315225003091/0001493152-25-003091-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000149315225003091/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T22:49:12.081981+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}